Maximizing Treatment Outcomes Through Strategic Patient Selection by HLA Matching
Time: 9:00 am
day: Conference Day Two
Details:
- Explore the criteria for identifying patients who are most likely to benefit from allogeneic therapies, focusing on genetic, clinical, and demographic factors
- How can we determine which patient is more likely to have increased allogeneic rejection?
